simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 39;5^{th}-Individual ID 39;5^{th}-Individual ID 39;5^{th}-Individual ID 39;5^{th}-Individual ID 39;;;95^{th}-Individual ID 6;95^{th}-Individual ID 6;95^{th}-Individual ID 6;95^{th}-Individual ID 6;95^{th}-Individual ID 6
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;0.405228084994633;-0.0666294194277437;0.267290365862665;0.458886781998471;-0.863324525397984;;;0.0348103178170421;-0.096830183967059;-0.0147765073039541;0.0294724988715146;-0.288501461917242
;0.404169361081318;-0.0726349868795812;0.264942009542528;0.449666650853139;-0.969765341115193;;;-8.09016005422518;-8.22058046406325;-8.14018259957296;-8.09677544846306;-8.39962620149289
;0.406286808907947;-0.0606238519759062;0.269638722182802;0.468106913143804;-0.756883709680775;;;8.15978068985926;8.02692009612913;8.11062958496505;8.15572044620609;7.82262327765841
;0.999997978077163;0.997599336570626;0.999977136088424;0.999880433296706;0.995517541956646;;;6.19649934358035e-05;0.00047940333067098;1.116476280838e-05;4.44053615498152e-05;0.00425288702947135
;1.22021397208689e-09;4.99572872325791e-05;4.63999636834769e-08;5.54906516916947e-07;0.000127540536051557;;;0.989977436017382;0.972124289993099;0.995745641721071;0.991515532124318;0.91702564182399
